Clinical study of the combination of small amount of nedaplatin (CDGP) /5-FU with radiation for the treatment of esophageal cancer

Japanese Journal of Gastroenterology

Volumn 99, Issue 10, 2002, Pages 1191-1196

  Inaba, Hiroyuki ^a   Tsuda, Takashi ^a   Miyazaki, Aya ^a   Watanabe, Yoshiyuki ^a   Nakaya, Shinichi ^a   Koitabashi, Yu ^a   Ogihara, Kyoko ^a   Hara, Takefumi ^a   Kato, Naoyuki ^a   Kobayashi, Yutaro ^a   Nakagawa, Teisuke ^a   Kitajima, Satoshi ^a   Endo, Toru ^a   Iino, Shiro ^a   Hoshikawa, Yoshikazu ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; NEDAPLATIN;

ADULT; AGED; ANEMIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; ESOPHAGUS CANCER; ESOPHAGUS DISEASE; FEMALE; HUMAN; LEUKOPENIA; MALE; NEUTROPENIA; THROMBOCYTOPENIA; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DRUG ADMINISTRATION SCHEDULE; ESOPHAGEAL NEOPLASMS; FEMALE; FLUOROURACIL; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; ORGANOPLATINUM COMPOUNDS; RADIOTHERAPY DOSAGE;

EID: 0036775826     PISSN: 04466586     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Trovo MG, Minatel E, Franchin G, et al: Radiotherapy versus radiotherapy enhanced by cisplatin in stage III non-small cell lung cancer. Int J Radiat Oncol Biol Phys 1992; 24: 11-15
2. Al-Sarraf M, Martz K, Herskovic A, et al: Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: An intergroup study. J Clin Oncol 1997; 15: 277-284
3. Decker DA, Drelichaman A, Jacobs J, et al: Adjuvant chemotherapy with cis-diamminedichloroplatinum II and 120-hour infusion 5-fluorouracil in Stage III and IV squamous cell carcinoma of the head and neck. Cancer 1983; 51: 1353-1355
4. Kelsen DP, Minsky B, Smith M, et al: Preoperative therapy for esophageal cancer: Arandomized comparison of chemotherapy versus radiation therapy. J Clin Oncol 1990; 8: 1352-1361
5. Murakami M, Kuroda Y, Nakajima T, et al: comparison between chemoradiation protocol intended for organ preservation and conventional surgery for clinical T1-T2 esophageal carcinoma. Int J Radiat Oncol Biol Phys 1999; 45: 277-284
6. Yamanaka H, Motohiro T, Michiura T, et al: Nedaplatin and 5FU Combined with Radiation in the Treatment for Esophageal Cancer. Jpn J Thorac Surg 1998; 46: 943-948
7. Sumi H, Ohtsu A, Boku N, et al: A case of Inoperable Esophageal Carcinoma with Hepatic and Nodal Metastases Which Showed a Long-term Survival after Chemoradiotherapy Including Nedaplatin. Jpn J Clin Oncol 2000: 406-409
8. DeConti RC, Toftness BR, Lange RC, et al: Clinical and pharmacological studies with cis-diamminedichloroplatinum (II). Cancer Res 1973; 33: 1310-1315
9. Drewinko B, Brown BW, Gottlieb JA: The effect of cis-diamminedichloroplatinum (II) on cultured human lymphoma cells and its therapeutic implications. Cancer Res 1973; 33: 3091-3095
10. Ehrlich CE, Einhorn L, Williams SD, et al: Chemotherapy for stage III-IV epithelial ovarian cancer with cis-dichlorodiammineplatinum (II), adriamycin, and cyclophosphamide: A preliminary report. Cancer Treat Rep 1979; 63: 281-288